Pliant Therapeutics, Inc. (PLRX) stock
PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.66−0.03 (-4.76%)
Close on Nov 17, 2026Market cap $40.88MP/E –Yield 0.00%
Pliant Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Pliant Therapeutics's pe ratio was 1.2× on Jan 29, 2021.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Jan 29, 2021 | 1.2× | +0.1 |
| 2020 | Dec 31, 2020 | 1.1× | – |
See a number that looks wrong?